Biomarkers in Olink Oncology II
-
5'-nucleotidase (5'-NT)
-
A disintegrin and metalloproteinase with thrombospondin motifs 15 (ADAM-TS 15)
-
Alpha-taxilin (TXLNA)
-
Amphiregulin (AREG)
-
Annexin A1 (ANXA1)
-
C-type lectin domain family 4 member K (CD207)
-
C-X-C motif chemokine 13 (CXCL13 )
-
Carbonic anhydrase IX (CAIX)
-
Carboxypeptidase E (CPE)
-
Carcinoembryonic antigen (CEA)
-
Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1)
-
Cathepsin L2 (CTSV)
-
CD160 antigen (CD160)
-
CD27 antigen (CD27)
-
CD48 antigen (CD48)
-
CD70 antigen (CD70)
-
Cornulin (CRNN)
-
Cyclin-dependent kinase inhibitor 1 (CDKN1A)
-
Delta-like protein 1 (DLL1)
-
Disintegrin and metalloproteinase domain-containing protein 8 (ADAM8)
-
Endothelial cell-specific molecule 1 (ESM-1)
-
Ephrin type-A receptor 2 (EPHA2)
-
Fas antigen ligand (FasL)
-
FAS-associated death domain protein (FADD)
-
Fc receptor-like B (FCRLB)
-
Fibroblast growth factor-binding protein 1 (FGF-BP1)
-
Folate receptor alpha (FR-alpha)
-
Folate receptor gamma (FR-gamma)
-
Furin (FUR)
-
Galectin-1 (Gal-1)
-
Glypican-1 (GPC1)
-
Granzyme B (GZMB)
-
Granzyme H (GZMH)
-
Hepatocyte growth factor (HGF)
-
ICOS ligand (ICOSLG)
-
Insulin-like growth factor 1 receptor (IGF1R)
-
Integrin alpha-V (ITGAV)
-
Integrin beta-5 (ITGB5)
-
Interferon gamma receptor 1 (IFN-gamma-R1)
-
Interleukin-6 (IL6)
-
Kallikrein-11 (hK11)
-
Kallikrein-13 (KLK13)
-
Kallikrein-14 (hK14)
-
Kallikrein-8 (hK8)
-
Ly6/PLAUR domain-containing protein 3 (LYPD3)
-
Melanoma-derived growth regulatory protein (MIA)
-
Mesothelin (MSLN)
-
Methionine aminopeptidase 2 (MetAP 2)
-
MHC class I polypeptide-related sequence A/B (MIC-A/B)
-
Midkine (MK)
-
Mothers against decapentaplegic homolog 5 (MAD homolog 5)
-
Mucin-16 (MUC-16)
-
Nectin-4 (PVRL4)
-
Pancreatic prohormone (PPY)
-
Podocalyxin (PODXL)
-
Pro-epidermal growth factor (EGF)
-
Protein CYR61 (CYR61)
-
Protein S100-A11 (S100A11)
-
Protein S100-A4 (S100A4)
-
Proto-oncogene tyrosine-protein kinase receptor Ret (RET)
-
R-spondin-3 (RSPO3)
-
Receptor tyrosine-protein kinase erbB-2 (ErbB2/HER2)
-
Receptor tyrosine-protein kinase erbB-3 (ErbB3/HER3)
-
Receptor tyrosine-protein kinase erbB-4 (ErbB4/HER4)
-
Secretory carrier-associated membrane protein 3 (SCAMP3)
-
Seizure 6-like protein (SEZ6L)
-
SPARC (SPARC)
-
Stem cell factor (SCF)
-
Syndecan-1 (SYND1)
-
T-cell leukemia / lymphoma protein 1A (TCL1A)
-
T-lymphocyte surface antigen Ly-9 (LY9)
-
TGF-beta receptor type-2 (TGFR-2)
-
Tissue factor pathway inhibitor 2 (TFPI-2)
-
TNF-related apoptosis-inducing ligand (TRAIL)
-
Toll-like receptor 3 (TLR3)
-
Transforming growth factor alpha (TGF-alpha)
-
Transmembrane glycoprotein NMB (GPNMB)
-
Tumor necrosis factor ligand superfamily member 13 (TNFSF13)
-
Tumor necrosis factor receptor superfamily member 19 (TNFRSF19)
-
Tumor necrosis factor receptor superfamily member 4 (TNFRSF4 )
-
Tumor necrosis factor receptor superfamily member 6B (TNFRSF6B)
-
Tyrosine-protein kinase ABL1 (ABL1)
-
Tyrosine-protein kinase Lyn (LYN)
-
Vascular endothelial growth factor A (VEGF-A)
-
Vascular endothelial growth factor receptor 2 (VEGFR-2)
-
Vascular endothelial growth factor receptor 3 (VEGFR-3)
-
VEGF-co regulated chemokine 1 (CXCL17)
-
Vimentin (VIM)
-
WAP four-disulfide core domain protein 2 (WFDC2)
-
Wnt inhibitory factor 1 (WIF-1)
-
WNT1-inducible-signaling pathway protein 1 (WISP-1)
-
Xaa-Pro aminopeptidase 2 (XPNPEP2)